Tirzepatide 10 mg/0.5 mL Sterile Solution, 2 mL Multi-dose vial, Rx only, This is a Compounded Product By: Revive RX Pharmacy, 3831 Golf Dr A, Houston, TX 77018, internally assigned NDC 99000-9278-64
Published June 5, 2024 · Recall initiated: April 20, 2024
Summary
FDA records drug Class I recall D-0511-2024, published June 5, 2024 and initiated April 20, 2024. Recalling firm: Revive Rx LLC dba Revive Rx Pharmacy; Status: Ongoing; Reported quantity: 751 vials; Lot: Lot #: 748127, Exp 9/24/2024. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Labeling: Label Mix-up - product labeled as tirzepatide contains testosterone cypionate
What to do
Voluntary: Firm initiated · Telephone
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Revive Rx LLC dba Revive Rx Pharmacy
- Distributor
- USA Nationwide
- Lot
- Lot #: 748127, Exp 9/24/2024
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAZoledronic Acid Injection 5mg/100mL Sterile Solution, 100mL Single-Dose vials, Rx only, Distributor: Dr.June 5, 2024
- FDAEpinephrine-Lidocaine HCl 0.25 mg/mL and 7.5 mg/mL Preservative-Free 1mL Single-Use vials for IntraocularJune 5, 2024
- FDACathflo activase (ALTEPLASE), 2mg vials, Rx only, Genentech Inc., South San Francisco, CA 94080, NDCJune 5, 2024
- FDADexamethasone-Moxifloxacin (1 mg/mL and 5mg/mL) Preservative-Free, 1mL Single-Use vials for IntraocularJune 5, 2024
- FDATirzepatide 10 mg/0.5 mL Sterile Solution-2 mL Vial, Rx Only, For Sub-Q Use Only, Compounded Drug Product By:May 31, 2023
- FDAHCG 6,000iu (lyo) Human Chorionic Gonadotropin Inj., For Sub-Q or IM Use Only, Not For IV Use, Vial, Rx Only,February 23, 2022
Questions about this recall
Was Tirzepatide 10 mg/0.5 mL Sterile Solution, 2 mL Multi-dose vial, Rx only, This is a Compounded Product By: Revive RX Pharmacy, 3831 Golf Dr A, Houston, TX 77018, internally assigned NDC 99000-9278-64 recalled?
Yes. FDA published recall D-0511-2024 on June 5, 2024. Reported hazard: Labeling: Label Mix-up - product labeled as tirzepatide contains testosterone cypionate
What should I do if I have this product?
Voluntary: Firm initiated · Telephone